Microsoft just walked away from a giant AI bet in Britain, and the reason is painfully unglamorous. Plus: a jittery earnings week and a satellite spat with real stakes.

Washington just trimmed the bill it's willing to pay for med school. Someone else is happy to cover the difference, for a price. A former bankruptcy judge thinks she already knows how this story ends, and it isn't pretty.

One of tech's boldest dealmakers has spotted his next big AI opportunity on the night shift. Investors flinched, hard. Masterstroke, or the priciest science experiment of the year?

A sequel nobody in Silicon Valley asked for is now in production. Eight states, one AI giant and a legal script that already cost Meta dearly. So who is actually writing the rules for AI now, and is it still Washington?

Saturday hit fast-forward on the robots and pause on the rules. Grab a coffee: one signature quietly undid another, and someone went shopping for a security army.

The world’s top finance ministers just agreed to practise for a disaster that hasn’t happened yet. The scary part isn’t the money that could vanish overnight. It’s the trust that could quietly go with it.

Some of America's biggest employers have found a new way to deliver bad news: very, very slowly. Staff know cuts are coming, just not who or when. So is it honesty, strategy, or something a little sneakier?

The world's most powerful central banker just said the quiet part out loud about the AI boom. It's not just a productivity miracle waiting in the wings — it's a bill landing right now. Guess who might be chipping in?

Friday ended with markets clutching their pearls and the oil price strutting around like it owned the place. Here's what rattled everyone, and what to watch next.

Two of the world's most valuable companies just paid $25 million apiece for a spot at a very exclusive White House dance. Nobody's entirely sure what that actually buys. And the music could stop in November.

Apple finally has the green light for its AI in China. The catch? It's arriving late, running on a rival's brain and leaving Siri at the border. Smart workaround, or a very expensive compromise?

Eli Lilly just became pharma's first trillion-dollar company. So naturally, its CEO is behaving like a man bracing for the worst. Here's why the smartest move at the top might be planning for the fall.